Artiva Biotherapeutics Statistics
NASDAQ: ARTVHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
6.94+0.14 (+2.06%)
At close: Oct 9, 4:00 PM ET · Delayed 15 min
After hours: 6.94 0.00%
Artiva Biotherapeutics by the numbers
Artiva Biotherapeutics has a market capitalization of $339.3 million based on 48.89M shares outstanding. With trailing EPS of $-3.23, Artiva Biotherapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 29.7% below its 50-day average and 12.4% below its 200-day average.
Average daily trading volume is 403.56K shares, or about $2.8 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
ARTV valuation vs. peer median
| Metric | ARTV | Peer median | Difference |
|---|---|---|---|
| Market cap | $339.30M | $347.68M | -2% |
| Avg. volume | 403.56K | 1.91M | -79% |
Peer median across 8 companies: AGEN, SRZN, CABA, OCGN, FENC, ZURA, CCCC, XFOR.
Valuation
- Market cap
- $339.30M
- EPS (TTM)
- $-3.23
- Shares outstanding
- 48.89M
Price and trading
- Previous close
- 6.80
- Open
- 6.84
- Day range
- 6.77 – 7.14
- 52-week range
- 2.71 – 14.53
- 52-week change
- +126.67%
- Beta
- —
- Volume
- 275.93K
- Average volume
- 403.56K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Aug 7, 2025
Additional statistics
- Market Cap
- 339.30M
- Forward Pe
- -2.66
- Eps
- -3.23
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 14.53
- Week52 Low
- 2.71
- Avg Volume
- 403.56K
- Shares Outstanding
- 48.89M
- Ma50
- 9.87
- Ma200
- 7.92
- Earnings Date
- Aug 7, 2025
- Pct From52w High
- -52.24%
- Pct From52w Low
- 156.09%